TERESA MCLEMORE: Open Payments
NPI 1922258268 · FORT WORTH, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$401 in 16 payments from 7 companies in 2025. Trend: 2023 $1,417 · 2024 $920 · 2025 $401
Food & beverage: $401
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 10 | $193 |
| Otsuka America Pharmaceutical, Inc. | 1 | $102 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $26 |
| KYOWA KIRIN, INC. | 1 | $25 |
| Mallinckrodt Hospital Products Inc. | 1 | $23 |
| Travere Therapeutics, Inc. | 1 | $17 |
| Recor Medical Inc | 1 | $15 |
Products named: KRYSTEXXA, JYNARQUE, CRYSVITA, ACTHAR, Paradise Ultrasound Renal Denervation System.
Industry payments across TX — which companies pay providers there.
